Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005805 · ClinicalTrials.gov registry record · Phase 3
St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer
A Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00005805: Completed Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00005805 is a Phase 3 study that has completed, run by Memorial Sloan Kettering Cancer Center. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00005805, a Phase 3 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
RATIONALE: Giving St. John's wort may be effective in relieving fatigue in patients with cancer who are undergoing chemotherapy or hormone therapy. PURPOSE: Randomized phase III trial to determine the effectiveness of St. John's wort in relieving fatigue in patients who are undergoing chemotherapy or hormone therapy for cancer.
Interventions
- DIETARY_SUPPLEMENT St. John's wort
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00005805
The ClinicalTrials.gov registry entry for NCT00005805 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which St. John's wort is the first listed.
NCT00005805 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00005805 about?
NCT00005805 is a clinical study titled "St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer". RATIONALE: Giving St. John's wort may be effective in relieving fatigue in patients with cancer who are undergoing chemotherapy or hormone therapy. PURPOSE: Randomized phase III trial to determine the effectiveness of St. John's wort in relieving fatigue in patients who are undergoing chemotherapy ...
What is the current status of trial NCT00005805?
This trial is currently completed. It is a Phase 3 study. The study started on 1999-12.
What interventions are being tested in trial NCT00005805?
The interventions under investigation include: St. John's wort (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00005805?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.